Piramal Pharma Limited
No trades
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 88.69 B INR, the most of which — 25.85 B INR — came from its top-performing segment, Other Commercial Manufacturing, compared to 24.84 B INR the previous year. The greatest contribution came from North America, which accounted for 35.48 B INR last year, with 32.94 B INR the year before.
By source
By country